摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-O-Benzoyl-4-O-(2,3-di-O-benzoyl-4-O-trityl-α-D-rhamnopyranosyl)-1,2-O-[1-(exo-cyano)ethylidene]-β-L-rhamnopyranose | 197246-78-9

中文名称
——
中文别名
——
英文名称
3-O-Benzoyl-4-O-(2,3-di-O-benzoyl-4-O-trityl-α-D-rhamnopyranosyl)-1,2-O-[1-(exo-cyano)ethylidene]-β-L-rhamnopyranose
英文别名
——
3-O-Benzoyl-4-O-(2,3-di-O-benzoyl-4-O-trityl-α-D-rhamnopyranosyl)-1,2-O-[1-(exo-cyano)ethylidene]-β-L-rhamnopyranose化学式
CAS
197246-78-9
化学式
C55H49NO12
mdl
——
分子量
915.994
InChiKey
LFKJRHYOZBVJGN-CAKLJYTASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    8.57
  • 重原子数:
    68.0
  • 可旋转键数:
    13.0
  • 环数:
    9.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    158.07
  • 氢给体数:
    0.0
  • 氢受体数:
    13.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-O-Benzoyl-4-O-(2,3-di-O-benzoyl-4-O-trityl-α-D-rhamnopyranosyl)-1,2-O-[1-(exo-cyano)ethylidene]-β-L-rhamnopyranose 在 Cl(3)HO4sodium methylate 作用下, 生成 Cyclopentakis[(1->4)-α-D-rhamnopyranosyl-(1->4)-α-L-rhamnopyranosyl]
    参考文献:
    名称:
    Achiral Cyclodextrin Analogues
    摘要:
    AbstractThe synthesis of a new family of cyclodextrin (CD) analogues is described. This family consists of novel cyclic oligosaccharides built from monosaccharides that possess the same relative but opposite absolute (D‐ and L‐) configurations. The alternation of such D‐ and L‐ residues—specifically, D‐ and L‐rhamnose or D‐ and L‐mannose—in a macrocyclic structure results in Sn‐type symmetry and, consequently, optical inactivity. The synthesis of these cyclic oligosaccharides was achieved by an economical polycondensation/cycloglycosylation approach that relies on an appropriately‐derivatized disac‐charide monomer and that avoids the time‐consuming, and often low‐yielding, stepwise growth of long linear oligosaccharide precursors. In the cases reported, the key precursors are the disaccharide monomers 1‐RR and 1‐MM, which bear both a glycosyl donor (cyanoethylidene function) and a glycosyl acceptor (trity‐loxy group). These compounds are able to undergo Tr+‐catalyzed polycondensation which, under appropriate dilution conditions, can be terminated by cycloglycosyl‐ation. Thus, compound 1‐RR was converted into a range of protected cyclic rhamnooligosaccharides 15–19 in 64% overall yield. All these products, including the unique cyclic dodeca‐ and tetradecasaccharides 18 and 19, have been isolated by preparative HPLC. Unexpectedly, treatment of the manno analogue of the disaccharide 1‐RR (compound 1‐MM) under the same conditions produced only the cyclic hexasaccharide 28 and numerous apparently linear oligomers. Removal of the protecting groups from 16–19 afforded the free cyclic oligosaccharides 21–24, which exhibited the predicted zero optical rotation and very simple NMR spectra, indicating highly symmetrical structures. X‐ray crystallography reveals that in the solid state the cyclooctaoside 21 possesses a C2 symmetric structure, on account of a slight deformation of its cylindrical shape. The channel‐type crystal packing of molecules of 21 forms nanotubes with an internal diameter of around 1 nm. Conversely, the cyclic hexasaccharide 29 possesses a Ci symmetric solid‐state structure and its molecules pack to form a parquet‐like superstructure.
    DOI:
    10.1002/chem.19970030818
  • 作为产物:
    参考文献:
    名称:
    Achiral Cyclodextrin Analogues
    摘要:
    AbstractThe synthesis of a new family of cyclodextrin (CD) analogues is described. This family consists of novel cyclic oligosaccharides built from monosaccharides that possess the same relative but opposite absolute (D‐ and L‐) configurations. The alternation of such D‐ and L‐ residues—specifically, D‐ and L‐rhamnose or D‐ and L‐mannose—in a macrocyclic structure results in Sn‐type symmetry and, consequently, optical inactivity. The synthesis of these cyclic oligosaccharides was achieved by an economical polycondensation/cycloglycosylation approach that relies on an appropriately‐derivatized disac‐charide monomer and that avoids the time‐consuming, and often low‐yielding, stepwise growth of long linear oligosaccharide precursors. In the cases reported, the key precursors are the disaccharide monomers 1‐RR and 1‐MM, which bear both a glycosyl donor (cyanoethylidene function) and a glycosyl acceptor (trity‐loxy group). These compounds are able to undergo Tr+‐catalyzed polycondensation which, under appropriate dilution conditions, can be terminated by cycloglycosyl‐ation. Thus, compound 1‐RR was converted into a range of protected cyclic rhamnooligosaccharides 15–19 in 64% overall yield. All these products, including the unique cyclic dodeca‐ and tetradecasaccharides 18 and 19, have been isolated by preparative HPLC. Unexpectedly, treatment of the manno analogue of the disaccharide 1‐RR (compound 1‐MM) under the same conditions produced only the cyclic hexasaccharide 28 and numerous apparently linear oligomers. Removal of the protecting groups from 16–19 afforded the free cyclic oligosaccharides 21–24, which exhibited the predicted zero optical rotation and very simple NMR spectra, indicating highly symmetrical structures. X‐ray crystallography reveals that in the solid state the cyclooctaoside 21 possesses a C2 symmetric structure, on account of a slight deformation of its cylindrical shape. The channel‐type crystal packing of molecules of 21 forms nanotubes with an internal diameter of around 1 nm. Conversely, the cyclic hexasaccharide 29 possesses a Ci symmetric solid‐state structure and its molecules pack to form a parquet‐like superstructure.
    DOI:
    10.1002/chem.19970030818
点击查看最新优质反应信息

同类化合物

(3-三苯基甲氨基甲基)吡啶 非马沙坦杂质1 隐色甲紫-d6 隐色孔雀绿-d6 隐色孔雀绿 隐色乙基结晶紫 降钙素杂质10 重氮四苯基乙烷 酸性黄117 酸性蓝119 酚酞啉 酚酞二硫酸钾水合物 萘,1-甲氧基-3-甲基 苯酚,4-(1,1-二苯基丙基)- 苯甲醇,4-溴-a-(4-溴苯基)-a-苯基- 苯甲醇,2-氨基-5-氯-a-乙烯基-a-苯基- 苯甲酸,4-(羟基二苯甲基)-,甲基酯 苯甲酸,3-[[2-[[(1,1-二甲基乙氧基)羰基]氨基]-3-[(三苯代甲基)硫代]丙基]氨基]-,(R)- 苯甲基N-[(2(三苯代甲基四唑-5-基-1,1联苯基-4-基]-甲基-2-氨基-3-甲基丁酸酯 苯基双-(对二乙氨基苯)甲烷 苯基二甲苯基甲烷 苯基二[2-甲基-4-(二乙基氨基)苯基]甲烷 苯基{二[4-(三氟甲基)苯基]}甲醇 苯基-二(2-羟基-5-氯苯基)甲烷 苄基2,3,4-三-O-苄基-6-O-三苯甲基-BETA-D-吡喃葡萄糖苷 苄基 5-氨基-5-脱氧-2,3-O-异亚丙基-6-O-三苯甲基呋喃己糖苷 苄基 2-乙酰氨基-2-脱氧-6-O-三苯基-甲基-alpha-D-吡喃葡萄糖苷 苄基 2,3-O-异亚丙基-6-三苯甲基-alpha-D-甘露呋喃糖 苄基 2,3,4-三-O-(苯基甲基)-6-O-(三苯基甲基)-ALPHA-D-吡喃甘露糖苷 芴甲氧羰基-4-叔丁酯-天冬酰胺-S-三氯苯甲基-L-半胱氨酸 膦酸,1,2-乙二基二(磷羧基甲基)亚氨基-3,1-丙二基次氮基<三价氮基>二(亚甲基)四-,盐钠 脱氢奥美沙坦-2三苯甲基奥美沙坦脂 美托咪定杂质28 绿茶提取物茶多酚陕西龙孚 结晶紫 磺基琥珀酰亚胺基-4-[2-(4,4-二甲氧基三苯甲基)]丁酸酯 磷,三(4-甲氧苯基)甲基-,碘化 碱性蓝 硫代硫酸氢 S-[2-[(3,3,3-三苯基丙基)氨基]乙基]酯 盐酸三苯甲基肼 白孔雀石绿-d5 甲酮,(反-4-氨基-4-甲基环己基)-4-吗啉基- 甲基三苯基甲基醚 甲基6-O-(三苯基甲基)-ALPHA-D-吡喃甘露糖苷三苯甲酸酯 甲基3,4-O-异亚丙基-6-O-三苯甲基-beta-D-吡喃半乳糖苷 甲基3,4-O-异亚丙基-2-O-甲基-6-O-三苯甲基吡喃己糖苷 甲基2-甲基-N-{[4-(三氟甲基)苯基]氨基甲酰}丙氨酸酸酯 甲基2,3,4-三-O-苯甲酰基-6-O-三苯甲基-ALPHA-D-吡喃葡萄糖苷 甲基2,3,4-三-O-苄基-6-O-三苯甲基-ALPHA-D-吡喃葡萄糖苷 甲基2,3,4-三-O-(苯基甲基)-6-O-(三苯基甲基)-ALPHA-D-吡喃半乳糖苷